High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy

Clinical trial NCT04201561 · UNKNOWN

Trial details

NCT number: NCT04201561
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy Recurrent Ovarian Carcinoma Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2019-12-24
Primary completion: 2023-04-30
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.